Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period
- 4 November 2020
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1430-1438
- https://doi.org/10.1016/j.kint.2020.10.018
Abstract
No abstract availableFunding Information
- National Cancer Institute
This publication has 44 references indexed in Scilit:
- Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?Journal for ImmunoTherapy of Cancer, 2019
- Review: Management of patients with kidney allograft failureTransplantation Reviews, 2018
- Calcineurin inhibitor withdrawal or tapering for kidney transplant recipientsEmergencias, 2017
- Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary PracticeTransplantation, 2017
- Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United StatesAmerican Journal of Transplantation, 2016
- Tumor Regression and Allograft Rejection after Administration of Anti–PD-1The New England Journal of Medicine, 2016
- Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell TransplantationAdvances in Chronic Kidney Disease, 2014
- KDIGO clinical practice guideline for the care of kidney transplant recipients: a summaryKidney International, 2010
- Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantationBlood, 2009
- Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysisThe Lancet, 2007